The VirtuE™ expression system has been developed for the purpose of producing
native-like proteins, which are widely adopted by leading in vitro diagnostic,
vaccine and academic groups in cutting-edge R&D, where correct folding
and glycosylation are vital. Our contract services range from antibody generation,
to scale production of recombinant and native antigens, and bespoke assay development and QC.
Building on recognised expertise in infectious diseases, The Native Antigen is
expanding their portfolio to include a range of disease-state markers and other critical
reagents for human health.
Via Umbria 10
20054 Segrate (Milano)
Tel. +39 02-26922300
Fax +39 02-26926058
Fax +39 02-26923535